Bayer prostate cancer medicine Nubeqa approved for expanded use in non-chemotherapy patients
This will offer clinicians access to a non-chemotherapy treatment option for patients who may not be able to tolerate chemotherapy
This will offer clinicians access to a non-chemotherapy treatment option for patients who may not be able to tolerate chemotherapy
What's Your Reaction?
DDP Editor
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
